Haemonetics down 7% on agreement loss from CSL Pharma

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Haemonetics down 7% on agreement loss from CSL Pharma

To read the full story on Seeking Alpha, click here.

Haemonetics (NYSE:HAE)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Haemonetics Charts.

Haemonetics (NYSE:HAE)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Haemonetics Charts.

Haemonetics Corp News

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
Wednesday 10 April 2024 (3 weeks ago) • PR Newswire (US)

Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
Thursday 4 April 2024 (4 weeks ago) • PR Newswire (US)

Haemonetics Corporation Completes Acquisition of Attune Medical
Monday 1 April 2024 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Tuesday 5 March 2024 (2 months ago) • PR Newswire (US)

Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
Wednesday 21 February 2024 (2 months ago) • PR Newswire (US)

Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
Wednesday 21 February 2024 (2 months ago) • PR Newswire (US)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)

More Haemonetics Corp News Articles

RespireRx Pharmaceuticals (PK)

Voip Pal Com (QB)

Global Developments (PK)

Brookmount Explorations (PK)

MicroCloud Hologram

BlackStar Enterprise (PK)

NaturalShrimp (QB)

Globestar Therapeutics (PK)

Seven Arts Entertainment (PK)

Moon Equity (PK)

Trump Media and Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions